Alethia Biotherapeutics announces the issuance of U.S. Patent No. 8,900,579 entitled “Siglec-15 antibodies in treating bone loss-related diseases” by the United States Patent and Trademark Office (“USPTO”)
Alethia Biotherapeutics announces the issuance of U.S. Patent No. 8,900,579 entitled “Siglec-15 antibodies in treating bone loss-related diseases” by the United States Patent and Trademark Office (“USPTO”)